In EAC, mutations in TP53 are detected early in the pathogenesis, likely linked to severe DNA damage in Barrett esophagus (BE) due to the reflux of mixed gastric and duodenal juice into the esophagus [9]. The gene discussed is TP53; the disease is esophageal adenocarcinoma.